<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="51939">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01886430</url>
  </required_header>
  <id_info>
    <org_study_id>FES</org_study_id>
    <nct_id>NCT01886430</nct_id>
  </id_info>
  <brief_title>Effects of Low-frequency Electrical Stimulation in Patients With Advanced HF</brief_title>
  <official_title>Effects of Low-frequency Electrical Stimulation in Sympathetic Nerve Activity and Peripheral Vasoconstriction in Patients With Advanced HF</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Sao Paulo General Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Fundação de Amparo à Pesquisa do Estado de São Paulo</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Coordenação de Aperfeiçoamento de Pessoal de Nível Superior.</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Sao Paulo General Hospital</source>
  <oversight_info>
    <authority>Brazil: Ethics Committee</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to verify the effects of low frequency functional electrical
      stimulation in heart failure patients hospitalized for treatment of the syndrome.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The aim of this study is to assess the effects of low frequency functional electrical
      stimulation on control autonomic and peripheral function in heart failure patients
      hospitalized for treatment of the syndrome. A randomized clinical trial with 30  advanced
      heart failure patients  will be randomly assigned to functional electrical stimulation
      (Functional EE, n= 15) e 2) sensory electrical stimulation (Sensory EE, n=15). The
      functional electrical stimulation will be applied in the rectus femoris, and gastrocnemius,
      with frequency of 10 Hz, pulse duration of 150 ms, stimulation time (time on) of 20 seconds,
      resting time (time off) of 20 seconds and intensity according to the discomfort threshold of
      the patient , checked every day until achieve a maximum of 70mA. The session will last 60
      minuts. It will be held every weekday for a period of 10 days. The effects of interventions
      on functional capacity, autonomic control, peripheral function, peripheral muscle strength
      and quality of life will be analyzed at baseline and at the end of the protocol.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>May 2009</start_date>
  <completion_date type="Anticipated">November 2014</completion_date>
  <primary_completion_date type="Anticipated">May 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Functional assessment</measure>
    <time_frame>10 days</time_frame>
    <safety_issue>No</safety_issue>
    <description>To assess the effects of the functional electrical stimulation in patients with advanced heart failure.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Peripheral function</measure>
    <time_frame>10 days</time_frame>
    <safety_issue>No</safety_issue>
    <description>To assess the effects of the functional electrical stimulation in patients with advanced heart failure.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Peripheral muscle strength</measure>
    <time_frame>10 days</time_frame>
    <safety_issue>No</safety_issue>
    <description>To assess the effects of the functional electrical stimulation in patients with advanced heart failure.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Heart Failure</condition>
  <arm_group>
    <arm_group_label>Functional Electrical Stimulation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Functional Electrical Stimulation for 10 days</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control Electrical Stimulation</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Control Electrical Stimulation for 10 days</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Functional electrical stimulation</intervention_name>
    <description>Functional electrical stimulation for 10 days</description>
    <arm_group_label>Functional Electrical Stimulation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with advanced heart failure,

          -  Class Functional IV, according to the criteria of New York Heart Association (NYHA),

          -  Aged over 18 years,

          -  Etiology hypertensive, ischemic, idiopathic or chagas disease,

          -  Left ventricular ejection fraction ≤ 30%.

        Exclusion Criteria:

          -  Patients with  hypertension lung disease and oxygen-dependent,

          -  Neurological and neuromuscular disease that presenting paresthesia or plegia of the
             lower limbs,

          -  Insulin-dependent diabetes mellitus (type I),

          -  Peripheral arterial occlusive disease,

          -  Peripheral neuropathy,

          -  Use of pacemaker or implantable cardiodefibrillator.
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Raphaela V Groehs, PhD student</last_name>
    <phone>+5511 26615099</phone>
    <email>raphaela.vilar@incor.usp.br</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Carlos Eduardo Negrao, PhD</last_name>
    <phone>+551126615099</phone>
    <email>cndnegrao@incor.usp.br</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Instituto do Coração - HC/FMUSP</name>
      <address>
        <city>Sao Paulo</city>
        <zip>05403-900</zip>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Carlos Eduardo Negrao, PHD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <verification_date>April 2013</verification_date>
  <lastchanged_date>June 21, 2013</lastchanged_date>
  <firstreceived_date>April 9, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Sao Paulo General Hospital</investigator_affiliation>
    <investigator_full_name>Raphaela Vilar Ramalho Groehs</investigator_full_name>
    <investigator_title>PhD student</investigator_title>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Heart Failure</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
